Metabolome analysis of cachexia and its circadian rhythms in patients with advanced pancreatic cancer.

Metabolome analysis of cachexia and its circadian rhythms in patients with advanced pancreatic cancer. - Metabolome analysis in advanced pancreatic cancer patients with cachexia.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000002384

Enrollment

Registered

2009-10-01

Start date

2009-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. histologically or cytologically diagnosed adenocarcinoma or adenosquamous carcinoma 2. locally advanced or metastatic pancreatic cancer 3. A) patients without cachexia B) patients with cachexia 4. age of 20 years or older 5. adequate baseline organ function 6. patients provided written informed consent

Exclusion criteria

Exclusion criteria: 1. resectable pancreatic cancer 2. pancreatic neuroendcrine carcinoma 3. chemotherapy within 1 week 4. surgery within 1 month 5. deffinitive radiotherapy within 1 month 6. palliative radiotherapy within 2 weeks 7. uncontroled infection 8. uncontroled diabetic mellitus 9. condition that required corticosteroid

Design outcomes

Primary

Measure	Time frame
The metabolites on cachexia by metabolom analysis	—

Secondary

Measure	Time frame
The circadian rhythms of the metabolites on cachexia	—

Countries

Japan

Contacts

Public ContactYutaka Fujiwara

Kobe University Graduate School of Medicine Medical Oncology

fu_ji_@yahoo.co.jp0783825111

Outcome results